Published in Adv Exp Med Biol on January 01, 1990
Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci (2011) 1.29
Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr (2006) 1.14
Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci (2007) 1.01
Fructo-oligosaccharides and intestinal barrier function in a methionine-choline-deficient mouse model of nonalcoholic steatohepatitis. PLoS One (2017) 0.75
A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem (1993) 3.79
Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell (1993) 2.75
Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene (1993) 2.25
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (1998) 2.24
X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain (1989) 2.10
Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J Immunol (1992) 2.02
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol (1992) 1.99
DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol (1992) 1.96
Comparative studies with various substrains of Mycobacterium bovis BCG on the production of an antigenic protein, MPB70. Infect Immun (1983) 1.83
Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J Biol Chem (1995) 1.81
Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst (1984) 1.80
Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77
In vivo effect of anti-asialo GM1 antibody on natural killer activity. Nature (1981) 1.71
Genetic recombination in mycobacteria. J Bacteriol (1973) 1.65
Total synthesis of a RNA molecule with sequence identical to that of Escherichia coli formylmethionine tRNA. Proc Natl Acad Sci U S A (1981) 1.63
Genetic control of resistance to Mycobacterium intracellulare infection in mice. Infect Immun (1984) 1.61
Strain difference of delayed-type hypersensitivity to BCG and its genetic control in mice. Infect Immun (1978) 1.59
Effect of fructo-oligosaccharides on intestinal microflora. Nahrung (1987) 1.59
Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression. J Natl Cancer Inst (1998) 1.54
Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder mice. Infect Immun (1980) 1.48
[Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi (1987) 1.48
Method for isolation of deoxyribonucleic acid from mycobacteria. J Bacteriol (1970) 1.47
Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer. Eur J Cancer (1999) 1.46
Improvement of apraxia of eyelid opening by wearing goggles. Lancet (2000) 1.45
Is xenotransplantability of human colon cancers in SCID mice affected by angiogenic factors? J Natl Cancer Inst (1998) 1.45
Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Am J Gastroenterol (2000) 1.41
Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology (2002) 1.41
Mouse ATF-2 null mutants display features of a severe type of meconium aspiration syndrome. J Biol Chem (1999) 1.39
Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc Natl Acad Sci U S A (1985) 1.39
Suppressive effects of 4-acetylaminophenylacetic acid (actarit) on experimental autoimmune encephalomyelitis in rats. Immunopharmacology (1998) 1.38
Genetic disease patterns in Japan: a review. Hum Biol (1992) 1.37
Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer (1999) 1.37
Synthesis of a gene for human growth hormone and its expression in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.34
A role for Fyn tyrosine kinase in the suckling behaviour of neonatal mice. Nature (1994) 1.32
GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.30
Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem (2001) 1.28
Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-alpha mRNA but not of IL-1 beta mRNA. J Immunol (1991) 1.28
The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine. J Pediatr (1966) 1.27
Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group. Lancet (1984) 1.24
Further studies of infectious DNA extracted from mycobacteriophages. J Exp Med (1966) 1.18
Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. Biochim Biophys Acta (1995) 1.16
Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study. Diabetes Obes Metab (2011) 1.16
Isolation and characterization of Desulfitobacterium sp. strain Y51 capable of efficient dehalogenation of tetrachloroethene and polychloroethanes. Biosci Biotechnol Biochem (2001) 1.16
Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer (1999) 1.16
Effects of granulocyte-macrophage colony-stimulating factor and colony-stimulating factor-1 on the proliferation and differentiation of murine alveolar macrophages. J Immunol (1988) 1.15
Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol (2000) 1.15
Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry (2005) 1.15
Comparison of corneal thickness measurements using Orbscan II, non-contact specular microscopy, and ultrasonic pachymetry in eyes after laser in situ keratomileusis. Br J Ophthalmol (2004) 1.14
Lipofection of synthetic oligodeoxyribonucleotide having a palindromic sequence of AACGTT to murine splenocytes enhances interferon production and natural killer activity. Microbiol Immunol (1994) 1.12
Multiple mating types of Mycobacterium smegmatis. Jpn J Microbiol (1976) 1.12
An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry (2000) 1.11
In vitro induction of suppressor T-cells in delayed-type hypersensitivity to BCG and an essential role of I-J positive accessory cells. Immunol Lett (1982) 1.11
Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microb Pathog (1987) 1.11
In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res (1988) 1.10
Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res (1992) 1.10
Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer. Int J Oncol (1998) 1.09
Nonsurgical management of patients with blunt hepatic injury: efficacy of transcatheter arterial embolization. AJR Am J Roentgenol (1997) 1.08
Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study. Diabetes Obes Metab (2012) 1.08
Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients. Diabetologia (1997) 1.07
Quantitative evaluation of the enhanced green fluorescent protein displayed on the cell surface of Saccharomyces cerevisiae by fluorometric and confocal laser scanning microscopic analyses. Appl Microbiol Biotechnol (2001) 1.07
Recombination between Mycobacterium smegmatis strains Jucho and Lacticola. Jpn J Microbiol (1971) 1.07
Effects of pterygium on corneal spherical power and astigmatism. Ophthalmology (2000) 1.06
Transplacental and transcolostral immunity to pertussis in a mouse model using acellular pertussis vaccine. J Infect Dis (1983) 1.06
Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Obstet Gynecol (1991) 1.06
Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry (2001) 1.06
Serum transferrin receptor as a new index of erythropoiesis. Blood (1987) 1.05
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry (2004) 1.05
A prospective, randomised comparison of single and three piece acrylic foldable intraocular lenses. Br J Ophthalmol (2004) 1.05
Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer. Int J Oncol (1998) 1.04
Effects of black current anthocyanoside intake on dark adaptation and VDT work-induced transient refractive alteration in healthy humans. Altern Med Rev (2000) 1.04
Nondigestibility of a new sweetener, "Neosugar," in the rat. J Nutr (1984) 1.03
Lack of binding of bacterial lipopolysaccharide to mouse lung macrophages and restoration of binding by gamma interferon. J Exp Med (1985) 1.02
Phage inactivation by an ethanol-ether extract of Mycobacterium smegmatis. Am Rev Respir Dis (1970) 1.02
Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci Biotechnol Biochem (1997) 1.01
Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res (1994) 1.01
Nature of the receptor substance of Mycobacterium smegmatis for D4 bacteriophage adsorption. J Bacteriol (1972) 1.01
Difference in antigen-presenting ability of macrophages between high- and low-responder mice in delayed-type hypersensitivity to Mycobacterium bovis BCG. Infect Immun (1980) 1.00
Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol (2000) 1.00
Vertical transmission of adult T-cell leukaemia virus. Lancet (1983) 1.00
Efferent targets of osseous CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: an ultramorphological study on their terminal-target relations. J Bone Miner Res (1997) 1.00
In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate. FASEB J (2000) 0.99
The MEK1-ERK map kinase pathway and the PI 3-kinase-Akt pathway independently mediate anti-apoptotic signals in HepG2 liver cancer cells. Int J Cancer (2001) 0.99
A serologic survey on equine influenza for the past ten years. Nihon Juigaku Zasshi (1978) 0.98
Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization. J Immunol (1989) 0.98
Images in cardiology: A case of anomalous origin of the right coronary artery from the pulmonary artery complicated by acute myocardial infarction. Heart (2005) 0.98
Deoxyribonucleic acids (DNA) and related compounds. XIII. Synthesis of DNA duplexes containing a ribosome binding site. Chem Pharm Bull (Tokyo) (1985) 0.97
Expression of angiostatic factors in colorectal cancer. Int J Oncol (1999) 0.96
Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res (1998) 0.96
Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 0.96
A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst (1994) 0.95
Quantitative evaluation of irregular astigmatism by fourier series harmonic analysis of videokeratography data. Invest Ophthalmol Vis Sci (1998) 0.95
Inflammatory pseudotumor of the spleen: US and MRI findings. Radiat Med (1998) 0.95
Orthostatic hypotension caused by a localised dorsal medullary tumour. J Neurol Neurosurg Psychiatry (1996) 0.94
TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes. J Immunol (1994) 0.94
Colonic varices as a result of persistent mesocolon of the ascending and descending colon. Endoscopy (2011) 0.94
Appearance of a cell surface antigen associated with the activation of peritoneal macrophages in mice. Microbiol Immunol (1982) 0.94
Granulocyte-macrophage colony-stimulating factor promotes the proliferation of human alveolar macrophages in vitro. J Immunol (1991) 0.94
Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J Biochem (1994) 0.93
Monoclonal antibodies directed against mouse macrophages in different stages of activation for tumor cytotoxicity. J Immunol (1983) 0.93
Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (2001) 0.93